Australia markets closed

Morgan Stanley (MS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
97.57+0.53 (+0.55%)
At close: 04:00PM EDT
97.92 +0.35 (+0.36%)
Pre-market: 08:19AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close97.04
Bid97.57 x 1000
Ask0.00 x 900
Day's range96.81 - 97.69
52-week range69.42 - 103.25
Avg. volume6,265,214
Market cap158.567B
Beta (5Y monthly)1.37
PE ratio (TTM)17.74
EPS (TTM)5.50
Earnings date16 July 2024
Forward dividend & yield3.40 (3.48%)
Ex-dividend date29 Apr 2024
1y target est99.05
  • Bloomberg

    MapLight Therapeutics Taps Morgan Stanley, Jefferies for IPO

    (Bloomberg) -- MapLight Therapeutics has picked Morgan Stanley and Jefferies Financial Group Inc. to lead an initial public offering, according to people familiar with the matter.Most Read from BloombergWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in Japan‘I Live in Hell’: Anti-Growth Fervor Grips US South After Pandemic BoomNvidia’s 591,078% Rally to Most Valuable Stock Came in WavesNvidia Becomes World’s Most Valuable Company as AI Rally Steams AheadI Didn’t Think Biden Affect

  • Zacks

    Morgan Stanley (MS) Rises Higher Than Market: Key Facts

    In the closing of the recent trading day, Morgan Stanley (MS) stood at $97.57, denoting a +0.55% change from the preceding trading day.

  • Investor's Business Daily

    Morgan Stanley Profit Popped Last Quarter; Has It Turned A Corner?

    Morgan Stanley shows rising price performance, earning an upgrade to its IBD Relative Strength Rating